You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune checkpoint inhibitor therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Quality of Life and Physical Fitness After Immune Checkpoint

    Completed
    • Melanoma
    • Non Small Cell Lung Cancer
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 3, 2023

      Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

      Not yet recruiting
      • Metastatic Melanoma
      • Advanced Melanoma
      • San Francisco, California
        University of California, San Francisco
      Jan 13, 2023

      The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

      Recruiting
      • Non-Small-Cell Lung Carcinoma
      • +3 more
      • Checkpoint Inhibitor, Immune
      • Elizabethtown, Kentucky
        Baptist Health Clinical Research
      Apr 25, 2022

      Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

      Recruiting
      • Cancer
      • +2 more
      • Fecal Microbiota Transplantation (FMT)
      • Zurich, Switzerland
        University of Zurich, University Hospital Zurich
      Jun 14, 2022

      Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • increasing total fiber intake
      • Montréal, Quebec, Canada
        Centre hospitalier de l'Université de Montréal (CHUM)
      Apr 6, 2023

      The Gut Immune System During Immune Checkpoint Inhibitor Therapy

      Recruiting
      • Cancer
      • sigmoidoscopies and and venous blood sampling
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 4, 2022

      Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation

      Completed
      • Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
      • Anti-PD-1 or anti-PD-L1
      • Montpellier, France
        UH Montpellier
      Dec 22, 2021

      Immune Checkpoint Inhibitor Monotherapy or Combined With

      Not yet recruiting
      • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Department of Minimally Invasive and Interventional Radiology, L
      Jan 30, 2023

      Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)

      Recruiting
      • Carcinoma
      • Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
      • Los Angeles, California
      • +2 more
      Nov 23, 2022

      Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

      Not yet recruiting
      • Metastatic Melanoma
      • Skin Cancer
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Mar 9, 2023

      Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • +3 more
      • Intensity Modulated Radiation Therapy
      • +3 more
      • (no location specified)
      Jul 11, 2023

      Healthcare Resource Utilization and Costs of Immune Checkpoint

      Completed
      • Melanoma
        • East Hanover, New Jersey
          Novartis
        May 12, 2023

        Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

        Not yet recruiting
        • Metastatic Pancreatic Cancer
        • Durvalumab
        • Rintatolimod
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus MC
        Jun 23, 2023

        Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

        Not yet recruiting
        • Immune-related Colitis
        • Colitis
        • Minneapolis, Minnesota
          University of Minnesota
        Feb 4, 2023

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

        Active, not recruiting
        • Gastrointestinal Cancer
        • New York, New York
        • +1 more
        Nov 29, 2022

        Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

        Active, not recruiting
        • Head and Neck Squamous Cell Carcinoma
        • +2 more
        • Nivolumab 480mg and surgical resection
        • Baltimore, Maryland
          Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
        Feb 25, 2022

        Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

        Recruiting
        • Immune-Mediated Colitis
        • Tofacitinib 10 mg
        • Montreal, Quebec, Canada
          Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
        May 11, 2022

        Establishment of Predictive Models of Checkpoint Inhibitor

        Not yet recruiting
        • Pneumonia, Interstitial
        • Immune checkpoint inhibitors(ICIs) therapy
        • (no location specified)
        Aug 19, 2021

        Gut and Tumor Microbiome in Advanced ER-positive and

        Not yet recruiting
        • Breast Cancer
        • Melanoma
        • Observation
        • (no location specified)
        Nov 6, 2023

        NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)

        Recruiting
        • Non-small Cell Lung Cancer
        • Squamous Cell Carcinoma of the Head and Neck
        • Immune checkpoint inhibitor
        • Radiation Therapy
        • Lexington, Kentucky
          University of Kentucky Markey Cancer Center
        Nov 10, 2022

        Cancer Trial in Helsinki, Turku (Electronic patient reported outcomes)

        Recruiting
        • Cancer
        • Electronic patient reported outcomes
        • Helsinki, Finland
        • +1 more
        Feb 23, 2021

        Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer and

        Recruiting
        • Non Small Cell Lung Cancer
        • immune therapy
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Jan 5, 2022